000 03024nam  2200469zi 4500
0019.940392
003CaOODSP
00520240823092723
006m     o  d f      
007cr cn|||||||||
008240710t20242024oncado  ob   f00| 0 eng d
020 |a9780660727288
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-638/2024E-PDF
24500|aDecision-making regarding the use of personal protective measures to prevent the spread of respiratory infectious diseases : |breport / |cprepared for the Public Health Agency of Canada.
264 1|aOttawa, Ontario : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2024.
264 4|c©2024
300 |a1 online resource (181 pages) : |billustrations, graphs, photographs + |e1 summary (13 unnumbered pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"Supplier name: Abacus Data."
500 |a"Contract number: CW2337715."
500 |a"Delivery date: March 25, 2024."
500 |a"Registration number: POR 085-23."
500 |aIssued also in French under title: Prise de décisions concernant le recours à des mesures de protection individuelle pour prévenir la propagation des maladies respiratoires infectieuses : rapport.
504 |aIncludes bibliographical references.
520 |a"The Public Health Agency of Canada (PHAC) and Health Canada need to understand how people make decisions regarding the use of public health measures (PHMs) to protect themselves and those around them from COVID-19 and other respiratory infectious diseases (RIDs). PHMs have been one of the primary tools available to public health organizations to reduce COVID-19 transmission in communities during the pandemic and for other infectious diseases"--Executive summary, page 7.
650 0|aCOVID-19 (Disease)|zCanada|xPrevention|xPublic opinion.
650 0|aRespiratory organs|xDiseases|zCanada|xPrevention.
650 0|aCOVID-19 (Disease)|xResearch|zCanada.
650 0|aPublic opinion|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7102 |aAbacus Data, |econsultant.
77508|tPrise de décisions concernant le recours à des mesures de protection individuelle pour prévenir la propagation des maladies respiratoires infectieuses : |w(CaOODSP)9.940393
85640|qPDF|s4.19 MB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/H14-638-2024-eng.pdf|zReport
85640|qPDF|s393 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/H14-638-2024-1-eng.pdf|zSummary
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/085-23-e/085-23-Report.html|zReport
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/085-23-e/summary/085-23-Summary.html|zSummary